O'Shaughnessy Asset Management, LLC Alkermes Plc. Transaction History
O'Shaughnessy Asset Management, LLC
- $12.1 Billion
- Q1 2025
A detailed history of O'Shaughnessy Asset Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 27,935 shares of ALKS stock, worth $741,674. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,935
Previous 14,203
96.68%
Holding current value
$741,674
Previous $408,000
125.98%
% of portfolio
0.01%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ALKS
# of Institutions
407Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$773 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$484 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$313 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$213 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$183 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.36B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...